Displaying posts published in

August 2020

AN EXTRAORDINARY WEEK IN ISRAEL

http://www.verygoodnewsisrael.blogspot.com

Nothing can top the announcement of the forthcoming establishment of full diplomatic relations between Israel and the United Arab Emirates. And it is possible that there could be similar news from other Arab countries in the near future.

In comparison, some “merely” exceptional Israeli news items include the installation of an Israeli aircraft safety system at Qatar’s Hamad International Airport;  an Israeli hospital performing Phase 3 testing of the Russian Covid-19 vaccine; 3 new Israeli irrigation projects in India; Israeli electric vehicle charging systems for Europe and another major boost for Israel’s prospects in the Tour de France. Michael Ordman

ISRAEL’S MEDICAL ACHIEVEMENTS
 
Covid-19 passive vaccine cures 3 Israelis. Three of the first critical Covid-19 patients treated with the new IgG plasma-derived “passive vaccine” product developed by Israel’s Kamada and Hadassah Medical Center (reported here previously), have made a rapid recovery and have now been discharged from Hadassah hospital.
https://www.jpost.com/health-science/first-3-israelis-treated-with-new-passive-vaccine-recover-leave-hospital-638431
 
Pluristem’s Covid-19 Phase 2 Germany trial. Israel’s Pluristem Therapeutics (reported here previously) has been approved by German’s health regulatory authority to conduct a Phase 2 clinical trial of its PLX PAD stem cells on 40 serious Covid-19 patients. Pluristem is already conducting a 140-patient Phase 2 trial in the US.
https://www.pluristem.com/wp-content/uploads/2020/08/PEI-Clearance-to-Commence-Phase-II-Study-in-Germany-FINAL-FOR-RELEASE.pdf
 
Previous TB vaccinations help young Covid-19 patients. Researchers at Israel’s Ben Gurion and Hebrew Universities have found that vaccinations given against Tuberculosis (BCGs) in the last 15 years reduced death rates and infection rates in COVID-19 patients under 24 years of age. Data from 55 countries was analyzed.
https://unitedwithisrael.org/israeli-corona-discovery-tuberculosis-shots-could-help-fight-covid-19/
https://www.mdpi.com/2076-393X/8/3/378
 
Hadassah tests Russia’s Covid-19 vaccine. Professor Zeev Rotstein, CEO of Jerusalem’s Hadassah Medical Center, has revealed that its clinic in Skolkovo, Moscow is involved in clinical safety trials of the new Russian Covid-19 vaccine. Phase 3 trials are still ongoing, even while Russia’s President Putin inoculated his family.
https://www.timesofisrael.com/israels-hadassah-says-its-involved-in-development-of-russian-covid-19-vaccine/
https://www.youtube.com/watch?v=pfDMrlsQJl8
 
The Israeli at Moderna’s vaccine project. This 30-minute video features Israel’s Dr. Tal Zaks – chief medical officer of Moderna, a front-runner in the race for a COVID-19 vaccine. He summarizes the progress of the latest trial, and how his education at BGU’s Joyce and Irving Goldman Medical School shaped his career.
https://www.youtube.com/watch?v=nhn_MX7XhUE
 
Approval to test treatment for advanced cancer. Israel’s KAHR Medical has received US FDA approval to begin Phase 1 & 2 clinical (human) trials of its DSP107 treatment of advanced solid tumors (reported here previously). The trials will assess DSP107 both by itself and in combination with Roche’s atezolizumab.
https://www.jpost.com/health-science/fda-gives-jerusalem-based-company-go-ahead-to-start-cancer-drug-trials-638355   https://www.youtube.com/watch?v=D2NLNV3CB2U  https://kahr-medical.com/technology/pipeline/
 
Stress relief pre surgery reduces metastatic risk. Tel Aviv University researchers reduced secondary cancer following colorectal tumor removal. Deralin and Etopan were given before and after surgery. 3 years later the cancer had spread significantly less than in a control group. Now pancreatic cancer patients will be tested.
https://www.eurekalert.org/pub_releases/2020-08/afot-tau080720.php (latest trial)
https://english.m.tau.ac.il/news/cancer-stress (2017 trial on breast cancer patients)
 
Moses 2.0 launched. (TY Atid-EDI) Israel-headquartered Lumenis (reported here previously) has launched a superior version 2.0 of its Moses platform for minimal and non-invasive laser removal of urinary (bladder) stones and other stones.  https://lumenis.com/medical/holmium-products/lumenis-moses-pulse-120h/
https://lumenis.com/medical/specialties/urology/resource-hub/lumenis-launches-next-generation-moses-2-0-holmium-laser-technology/   
 
Home ultrasound for pregnant Israelis. Israeli healthcare provider Clalit, with 4.6 million Israeli members, has authorized the use of the PulseNmore home ultrasound device (see here) for expectant mothers. It will reduce numbers of unnecessary hospital visits (average two per pregnancy) during the Covid-19 pandemic.
https://www.timesofisrael.com/clalit-to-offer-pregnant-members-startup-pulsenmores-at-home-ultrasound-kit/   https://www.youtube.com/watch?v=YLskCQS79P4
 
From drip irrigation to diagnosing diseases. Kibbutz Hatzerim is famous for founding drip-irrigation innovator Netafim. It has now co-founded Picodya – developer of the B-Matrix in vitro diagnostics (IVD) platform. B-Matrix gives 15-30min test results for cancer, cardiac dysfunction and viruses (including Covid).
https://www.calcalistech.com/ctech/articles/0,7340,L-3844490,00.html   https://picodya.com/
https://picodya.com/wp-content/uploads/2020/04/PicodyaBMatrixTechnology.mp4
 
Signs of the times. The vital signs monitoring tool from Israel’s Binah.ai (reported here previously) is to be used by 4 Japanese companies. NTT Data – Health Data Bank; Alm’s MySOS – emergencies & new Covid-19 cases; Macnica Networks – monitoring Covid-19 re-infections; SOMPO – insurance policyholder checkups.
https://www.calcalistech.com/ctech/articles/0,7340,L-3844709,00.html
 
Canon partners Zebra. Israel’s Zebra Medical Vision (reported here previously) has partnered with American radiology system distributor, Canon Medical Systems USA (part of the Canon empire). Zebra’s disease analysis platform will be made available to many more locations across the United States.
https://www.calcalistech.com/ctech/articles/0,7340,L-3844686,00.html
https://us.medical.canon/news/press-releases/2020/08/11/3390/